Multiple New Team Members Hired for Expanding MedEvoke Business

HIGH BRIDGE, N.J., February 26, 2018 (Newswire.com) - MedEvoke is experiencing tremendous growth and expansion of its services. To strengthen the company and continue to provide excellent delivery, MedEvoke has announced several executive key additions to the team.

Dover Bull has been hired as Director Strategic Accounts. Dover is a highly accomplished pharmaceutical professional with over 15 years of experience in consulting, marketing strategy, and a deep understanding of selling to pharmaceutical companies. She most recently was CEO/President of CONNX Clinical Solutions and BioPharm Communications, as the SVP Sales & Marketing. She has extensive experience in strategy, problem-solving, and business development. Dover is known for her innovative and strategic thinking.

Due to new innovations and the increasing demand from our clients, we are experiencing tremendous growth. I am very pleased and fortunate to identify individuals who have the talent and personality that fits our positive, energetic, and passionate culture. We view these appointments as a sign of our commitment to be a leader in our industry. We continue to look forward to leveraging our medical strategy, content, analytics, and insights expertise and playing a key role in providing and implementing high-quality solutions with exceptional ROI for our clients.

Marc Sirockman, Chief Strategic Officer, Managing Director at MedEvoke

Joe Cikowski joins the MedEvoke team as Director Strategic Accounts. Joe brings with him over 20 years of agency, consulting, business development, strategy, and pharmaceutical experience. He most recently was with Mallinckrodt Pharmaceuticals as Market Development Manager, Autoimmune, and Rare Diseases and prior to that at Novartis Pharmaceuticals as the Regional Sales Manager, Neurology. With immense knowledge of cross-functional strategic account planning and tactical implementation, Joe is poised to make an immediate impact on our business.

Mark Jones also joins the team as Director Strategic Accounts. Mark is a pharmaceutical marketing professional with over 20 years of advertising agency experience, specializing in consumer and healthcare professional pharmaceutical marketing, strategy development, and new business. He most recently was the Group Director for Team Pfizer at Y&R and Group Account Director at Geometry Global. He has a strong understanding of sales, account growth, marketing, and client needs. Mark has a passion for brand marketing and believes in growing businesses through strong strategic planning and exceptional execution.

Barbara Zolli joins MedEvoke as a Medical Writer. Barb has over 25 years of healthcare, medical education, communications, and marketing experience. She most recently was Director, Content Management with Phoenix Marketing Solutions. She has a wealth of experience in content development for a wide variety of therapeutic areas. Barb has worked with a variety of business partners, overseeing teams to ensure successful delivery of projects/programs. She has account management, publication planning, and program design experience.

Jennifer Sootkoos joins MedEvoke as a Project Manager. Jennifer is a client service professional with over 16 years of quality assurance, project management and regulatory experience in the pharmaceutical industry. She was most recently a Regulatory Associate in the Global Regulatory Affairs group at Eli Lilly. She has a strong understanding of project management, global issues, and client deliverables. Jennifer joins the team to ensure successful delivery of projects.

MedEvoke is a digitally-oriented medical strategy and communications firm focused on integrating scientific content with data analytics to drive change and growth for the world's leading biopharmaceutical medical affairs teams. MedEvoke is built on insight integration, a content development approach founded on discovering transformative insights related to scientific exchange and integrating them into key functional areas. MedEvoke leverages its proven expertise and a powerful methodology, to ensure biopharmaceutical organizational alignment by reconciling client competing goals, objectives, languages, cultures, and budgets across the many global, regional, and affiliate operational functions. MedEvoke’s approach mitigates the risks associated with duplicated effort, unclear direction, and poor communications, ensuring global message alignment that evolves and withstands organizational change and market dynamics.

Effectively defining product positioning enables our clients to take control of how they are perceived in the competitive landscape and ensure clear, consistent, undiluted messages creating a single voice, shared across all internal and external stakeholders. Expertise is at the core of our work from single product launches to life-cycle management to enterprise/portfolio solutions. Our expertise spans most therapeutic areas and leverages proficiency in data analysis, global group dynamics, medical communications, and organizational alignment.

Marc Sirockman, Chief Strategic Officer, Managing Director said, “Due to new innovations and the increasing demand from our clients, we are experiencing tremendous growth. I am very pleased and fortunate to identify individuals who have the talent and personality that fits our positive, energetic, and passionate culture. We view these appointments as a sign of our commitment to be a leader in our industry. We continue to look forward to leveraging our medical strategy, content, analytics, and insights expertise and playing a key role in providing and implementing high-quality solutions with exceptional ROI for our clients.”

MedEvoke is a privately held company established in 1999.